Awards Harvard Seniors with Concentrations in Neuroscience Named Rhodes Scholars Harvard University Department of Molecular and Cellular Biology | December 9, 2024 Two Harvard seniors, Aneesh Muppidi ’25 and Ayush Noori ‘25, have been named Rhodes Scholars…karnottDecember 9, 2024 Read More
Local News Early Detection and Interception Research Shows Promise at ASH Dana-Farber Cancer Institute | December 6, 2024 Dana-Farber Cancer Institute investigators are leading three separate studies with encouraging results related to the…karnottDecember 6, 2024 Read More
Local News Whitehead Institute Builds Scientific Bridges to Advance Human Health Whitehead Institute | December 6, 2024 Since its inception, Whitehead Institute has driven groundbreaking discoveries in the basic biology of health…karnottDecember 6, 2024 Read More
Local News Scientists Create First Blueprint of Entire Mouse Gut Harvard Medical School | December 5, 2024 The intestine maintains an exquisitely delicate balance in the body, absorbing nutrients and water while…karnottDecember 5, 2024 Read More
Publications of the Week Increased Expression of Schizophrenia-Associated Gene C4 Leads to Hypoconnectivity of Prefrontal Cortex and Reduced Social Interaction Comer, A., L., et al. | January 22, 2020 Schizophrenia is a severe mental disorder with an unclear pathophysiology. Increased expression of the immune…sciencecityJanuary 22, 2020 Read More
Publications of the Week Targeting Rictor Sensitizes SMAD4-Negative Colon Cancer to Irinotecan Wong, C., K., et al. | January 15, 2020 Deciphering molecular targets to enhance sensitivity to chemotherapy is becoming a priority for effectively treating…sciencecityJanuary 15, 2020 Read More
Publications of the Week Generation of Mesenchyme Free Intestinal Organoids from Human Induced Pluripotent Stem Cells Mithal, A., et al. | January 14, 2020 Efficient generation of human induced pluripotent stem cell (hiPSC)-derived human intestinal organoids (HIOs) would facilitate…sciencecityJanuary 14, 2020 Read More
Publications of the Week Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS Chao C., et al. | January 13, 2020 My lab is focused on the identification of molecular mechanisms by which the environment, the…sciencecityJanuary 13, 2020 Read More
Local News Applications Open for the 2024 Pathbreakers Program by Novo Nordisk and Portal Innovations PR Newswire | December 15, 2023 This week, Novo Nordisk’s Bio Innovation Hub in Boston/Cambridge, in collaboration with Portal Innovations, just…karnottDecember 15, 2023 Read More
Local News Is This a Faster, Better Treatment for Blood and Solid Tumor Cancers? Northeastern Global News | December 15, 2023 A Northeastern researcher in the Department of Pharmaceutical Sciences and the New England Inflammation and…karnottDecember 15, 2023 Read More
Local News Bluebird Bio Receives US FDA Nod for Sickle Cell Therapy BioProcess International | December 15, 2023 The US Food and Drug Administration (FDA) has approved bluebird’s Lyfgenia (lovotibeglogene autotemcel) for the…karnottDecember 15, 2023 Read More
Local News Demystifying a Mammal’s Brain, Cell by Cell The Harvard Gazette | December 14, 2023 A group of scientists, including several at Harvard, have dived deeper into the mammalian brain…karnottDecember 14, 2023 Read More
Awards CMIT Clinical Scientist Receives IBD Journal Award The Center for Microbiome Informatics & Therapeutics (CMIT) | March 31, 2025 CMIT Clinical Scientist Marjolein Klaassen, MD, PhD was selected for the Inflammatory Bowel Diseases journal’s…karnottMarch 31, 2025 Read More
Local News FDA Approves Dual-Action Drug for Patients With Previously Treated Advanced Neuroendocrine Tumors, Backed by Dana-Farber Research Dana-Farber Cancer Institute | March 31, 2025 Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug…karnottMarch 31, 2025 Read More
Local News Engineers Develop a Better Way To Deliver Long-Lasting Drugs MIT News | March 31, 2025 MIT engineers have devised a new way to deliver certain drugs in higher doses with…karnottMarch 31, 2025 Read More